Back
Protagonist Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
PTGX
Protagonist Therapeutics, Inc.
Last Price:
$86.04
Seasonality Move:
29.24%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight selling pressure.
Protagonist Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.81 | Sell |
| 20-day SMA: | 89.08 | Sell |
| 50-day SMA: | 83.33 | Buy |
| 200-day SMA: | 60.62 | Buy |
| 8-day EMA: | 45.96 | Buy |
| 20-day EMA: | 22.55 | Buy |
| 50-day EMA: | 9.84 | Buy |
| 200-day EMA: | 2.57 | Buy |
Protagonist Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.32 | Buy |
| Relative Strength Index (14 RSI): | 47.73 | Sell |
| Chaikin Money Flow: | -261659 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (84.98 - 91.4) | Sell |
| Bollinger Bands (100): | (58.21 - 84.43) | Buy |
Protagonist Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics, Inc. Stock
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 86.05 while PTGX 8-day simple moving average is 90.81, which is a Sell signal.
-
The stock price of PTGX is 86.05 while Protagonist Therapeutics, Inc. 20-day SMA is 89.08, which makes it a Sell.
-
Protagonist Therapeutics, Inc. 50-day simple moving average is 83.33 while PTGX share price is 86.05, making it a Buy technically.
-
PTGX stock price is 86.05 and Protagonist Therapeutics, Inc. 200-day simple moving average is 60.62, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
39
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Is Protagonist Therapeutics, Inc. a Buy or a Sell?
-
Protagonist Therapeutics, Inc. stock is rated a SellThe current Protagonist Therapeutics, Inc. [PTGX] share price is $86.05. The Score for PTGX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics, Inc. Stock Info
Market Cap:
5.4B
Price in USD:
86.05
Share Volume:
1.7M
Protagonist Therapeutics, Inc. 52-Week Range
52-Week High:
96.54
52-Week Low:
33.70
Sell
39
Protagonist Therapeutics, Inc. (PTGX)
is a Sell
Protagonist Therapeutics, Inc. Share Price Forecast
-
What is the Protagonist Therapeutics, Inc. stock price today?The Protagonist Therapeutics, Inc. stock price is 86.05 USD today.
-
Will PTGX stock go up or go down?Protagonist Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Protagonist Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics, Inc. is overvalued.
Is Protagonist Therapeutics, Inc. Stock a Buy?
-
Protagonist Therapeutics, Inc. share price is 86.05 while PTGX 8-day exponential moving average is 45.96, which is a Buy signal.
-
The stock price of PTGX is 86.05 while Protagonist Therapeutics, Inc. 20-day EMA is 22.55, which makes it a Buy.
-
Protagonist Therapeutics, Inc. 50-day exponential moving average is 9.84 while PTGX share price is 86.05, making it a Buy technically.
-
PTGX stock price is 86.05 and Protagonist Therapeutics, Inc. 200-day simple moving average is 2.57, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics, Inc.
Is Protagonist Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.50 per share, and an increase next year of $2.93 per share.
Technical Analysis of Protagonist Therapeutics, Inc.
Should I short Protagonist Therapeutics, Inc. stock?
-
PTGX Moving Average Covergence Divergence (MACD) indicator is 16.32, suggesting Protagonist Therapeutics, Inc. is a Buy
-
Protagonist Therapeutics, Inc. Relative Strength Index (RSI) is 47.73, which suggest Protagonist Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Protagonist Therapeutics, Inc. is (84.98 - 91.4), which suggest Protagonist Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Protagonist Therapeutics, Inc. is (58.21 - 84.43), which suggest Protagonist Therapeutics, Inc. is a Buy
* Protagonist Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.